Quest Diagnostics Inc
DUS:QDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Quest Diagnostics Inc
DUS:QDI
|
US |
|
Block Inc
F:SQ3
|
US |
Intrinsic Value
The intrinsic value of
Quest Diagnostics Inc (QDI) under the Base Case is 205.66 EUR per share.
Compared with the current market price of 224.3 EUR, the stock appears
Overvalued by 8% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Quest Diagnostics Does
Quest Diagnostics is one of the largest clinical laboratory companies in the United States. It runs labs and patient service centers that collect and analyze blood, urine, and other samples for doctors, hospitals, health plans, employers, and consumers. The company helps answer a basic medical question: what is going on inside the body and what treatment should come next.
- Headquarters
- United States of America US
- Employees
- 51 500
- IPO date
- Dec 17, 1996
Quest Diagnostics has a narrow economic moat
Spreading laboratory and sample-transport costs across a large volume of tests helps Quest Diagnostics offer prices that smaller laboratories struggle to match. This makes its established testing system difficult to copy profitably, although large rivals such as Labcorp provide meaningful competition.
Read the full moat analysis
Revenue & Expenses Breakdown
Quest Diagnostics Inc
Earnings Waterfall
Quest Diagnostics Inc
The intrinsic value for
Quest Diagnostics Inc (QDI) under the Base Case is 205.66 EUR.
Compared with the current market price of 224.3 EUR, the stock appears Overvalued by 8% .